beta
/AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)